| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 8, 2005
Accepted on November 1, 2005
From the Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics (D.T., R.B., W.W., I.H., J.T.), University Hospital Leipzig, Leipzig; and the Department of Experimental Animal Research (K.N.), University Hospital Goettingen, Germany.
* To whom correspondence should be addressed. E-mail: thiery{at}medizin.uni-leipzig.de.
Objective--Our laboratory has previously created 2 strains of rabbits with genetically determined high- and low- (LAR) atherosclerotic response. The aim of the present study was to identify new genes of atherosclerosis susceptibility in macrophages from the 2 strains.
Methods and Results--Suppression subtractive hybridization was used to screen for genes with higher expression in macrophages from LAR rabbits. We identified a cDNA fragment with high homology to human arginase I (AI; 91%) and subsequently cloned the full-length cDNA of the rabbit homologue. Quantitative RT-PCR revealed a significantly higher macrophage AI mRNA expression in LAR rabbits than in high-atherosclerotic response rabbits (77428±10941 versus 34344±4538; P=0.002; copies/106 copies
-actin), which also correlated with a significantly higher arginase enzyme activity. Northern blot analysis led to the identification of a full-length polymorphism of AI mRNA. This was because of a 413 bp C-repeat insertion in the 3' untranslated region. The shorter transcript variant was predominantly expressed in LAR rabbits and associated with significantly higher AI mRNA expression levels. Transfection experiments indicated decreased mRNA stability of the long AI variant.
Conclusions--High expression of arginase I in macrophages may contribute to atherosclerosis resistance of LAR rabbits, possibly by conferring antiinflammatory effects in the vessel wall.
Related Article:
This article has been cited by other articles:
![]() |
R. I. Levin Arginine and Old MACE Small Molecules in Atherogenesis Support the Concept of Coronary Artery Disease as a Complex Trait. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2068 - 2069. [Full Text] [PDF] |
||||
![]() |
D. Teupser, S. Wolfrum, M. Tan, A. D. Persky, H. M. Dansky, and J. L. Breslow Novel Strategy Using F1-Congenic Mice for Validation of QTLs: Studies at the Proximal Chromosome 10 Atherosclerosis Susceptibility Locus Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 678 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gallardo-Soler, C. Gomez-Nieto, M. L. Campo, C. Marathe, P. Tontonoz, A. Castrillo, and I. Corraliza Arginase I Induction by Modified Lipoproteins in Macrophages: A Peroxisome Proliferator-Activated Receptor-{gamma}/{delta}-Mediated Effect that Links Lipid Metabolism and Immunity Mol. Endocrinol., June 1, 2008; 22(6): 1394 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dumont, M. Zureik, D. Cottel, M. Montaye, P. Ducimetiere, P. Amouyel, and T. Brousseau Association of arginase 1 gene polymorphisms with the risk of myocardial infarction and common carotid intima media thickness J. Med. Genet., August 1, 2007; 44(8): 526 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Thomas, G. B. Sala-Newby, Y. Ismail, J. L. Johnson, G. Pasterkamp, and A. C. Newby Genomics of Foam Cells and Nonfoamy Macrophages From Rabbits Identifies Arginase-I as a Differential Regulator of Nitric Oxide Production Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 571 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz and C. A. Reardon Arginine/Arginase NO NO NO Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 237 - 239. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |